Browse > Article
http://dx.doi.org/10.5392/JKCA.2022.22.02.782

Estimation of the Cost of Hypertension Disease Loss in 2010-2017 Using Cohort at Diagnosis Age and Treatment Time  

Noh, Yun-Gon ((주)제이엘케이)
Lee, Sang-Ho ((주)헬스맥스)
Choi, Kyungsik ((주)헬스맥스)
Song, Tae Min (삼육대학교)
Publication Information
The Journal of the Korea Contents Association / v.22, no.2, 2022 , pp. 782-793 More about this Journal
Abstract
The rise in chronic disease not only has a negative effect on people's lives, but it also increases the cost of medical care owing to the increased usage of medical care as health and medical technology improves, life expectancy rises, and rapid population ageing. In such context, this study examined the difference in the disease cost of hypertension according to demographic information and the effect of the initial diagnosis age and treatment period on the cost. This study used the Korean Health Panel Survey from 2010 to 2017, and selected subjects based on health insurance beneficiaries between the ages of 30 and under 80. With the selected data, the direct and indirect costs of disease loss were calculated according to the cost of illness approach, and we constructed a disease-loss ratio cohort considering the age of diagnosis and time of treatment for hypertension. From the results of the study, the annual cost of disease loss for hypertensive patients differed by gender by 110,107 won, and it was found that the cost increased by 1.8 times as the treatment time increased. In addition, when comparing disease loss ratios between the same age groups, it was found that the disease loss ratios between those in their 60s and 70s were affected by treatment time. This study confirmed that hypertension significantly affects the cost of the disease, and not only requires early diagnosis and management, but also preventive efforts to lower the incidence of hypertensive disease must be strengthened.
Keywords
Hypertension Cost; Medical Cost; Cost of Illness; Diagnosis Age; Treatment Time;
Citations & Related Records
Times Cited By KSCI : 4  (Citation Analysis)
연도 인용수 순위
1 조형경, 이현지, 설진주, 이광수, "고혈압 진단자의 혈압 관리를 위한 외래 방문 영향 요인," 병원경영학회지, 제26호, 제2권, pp.56-67, 2021.
2 전성연, 이상아, 장성현, 송선옥, 김현기, 임현선, 최정규, 박해용, 윤소라, 손강주, 고혈압을 중심으로 한의원급 만성질환관리제의 비용-효과분석, 국민건강보험일산병원, 2020.
3 E. Adane, A. Atnafu, and A. Y. Aschalew, "The Cost of Illness of Hypertension and Associated Factors at the University of Gondar Comprehensive Specialized Hospital Northwest Ethiopia," ClinicoEconomics and outcomes research : CEOR, Vol.12, pp.133-140, 2015.   DOI
4 정영호, "질병의 사회경제적 비용과 건강친화적 재정정책," 보건복지포럼, No.9, pp.50-61, 2009.
5 C. Park, J. Famg, N. A. Hawkins, and G. Wang, "Comorbidity Status and Annual Total Medical Expenditures in U.S. Hypertensive Adults," Am J Prev Med, Vol.53, No.6, pp.172-181, 2017.
6 B. Kirkland, M. Heincelman, G. Bishu, O. Schumann, A. Schreiner, R. Neal Axon, D. P. Mauldin, and P. Moran, "Trends in Healthcare Expenditures Among US Adults With Hypertension: National Estimates, 2003-2014," Journal of the American Heart Association, Vol.7, No.11, pp.1-9, 2018.
7 정영호, 고숙자, 김은주, 효과적인 만성질환 관리방안 연구, 한국보건사회연구원, 2013.
8 W. N. Burton, C. Chen, D. J. Conti, A. B. Schultz, G. Pransky, and D. W. Edington, "The Association of Health Risks With On-the-Job Productivity," Journal of Occupational and Environmental Medicine, Vol.47, No.8, pp.769-777, 2005.   DOI
9 T. R. Hird, E. Zomer, A. J. Owen, D. J. Magliano, D. Liew, and Z. Ademi. "Productivity Burden of Hypertension in Australia," Hypertension, Vol.73, No.4, pp.777-784, 2019.   DOI
10 C. Jo, "Cost-of-illness studies: concepts, scopes, and methods," Clin Mol Hepatol, Vol.20, No.4, pp.327-337, 2014.   DOI
11 R. Z. Goetzel, S. R. Long, R. J. Ozminkowski, K. Hawkins, S. Wang, and W. Lynch, "Health, absence, disability, and presenteeism cost estimates of certain physical and mental health conditions affecting U.S. employers," J Occup Environ Med, Vol.46, No.4, pp.398-412, 2004.   DOI
12 M. M. Sorato, M. Davari, A. Kebriaeezadeh, N. Sarrafzadegan, and T, Shibru, "Paid and unpaid work productivity loss associated with treated hypertension in Southern Ethiopia: a patient-level analysis," Journal of Pharmaceutical Health Services Research, No.70, p.70, 2022.
13 E. Adane, A. Atnafu, and A. Y. Aschalew, "The Cost of Illness of Hypertension and Associated Factors at the University of Gondar Comprehensive Specialized Hospital Northwest Ethiopia," Clinicoecon Outcomes Res, Vol.12, pp.133-140, 2018.
14 정영호, Health Plan 2020의 건강성과에 대한 기대효과, 한국보건사회연구원, 건강증진사업지원단, 2011.
15 오승원, 정기택, 박지령, "근로자의 건강위험요인과 결근율, 프리젠티즘의 관련성," 대한산업의학회지, 제19권, 제4호, pp.303-314, 2007.
16 조경숙, "우리나라 만성질환의 발생과 관리 현황," 질병관리본부 주간 건강과 질병, 제14권, 제4호, pp.166-177, 2021.
17 G. Wang, S. D. Grosse, and M. W. Schooley, "Conducting Research on the Economics of Hypertension to Improve Cardiovascular Health," American journal of preventive medicine, Vol.53, No.6, pp.115-117, 2017.
18 K. T. Mills, A. Stefanescu, and J. He, "The global epidemiology of hypertension," Nat Rev Nephrol, Vol.16, No.4, pp.223-237, 2020.   DOI
19 World Health Organization, A Global Brief on Hypertension: Silent Killer, Global Public Health Crisis: World Health Day 2013, 2013.
20 손민성, 김한결, 이현실, 최만규, "복합만성질환이 의료비 지출에 미치는 종단적 영향 및 과부담 의료비 발생의 전환점(cut-off point) 예측," 보건경제와 정책연구, 제24권, 제3호, pp.49-75, 2018.
21 G. Chodick, A. Porath, A. Alapi, T. Sella, S. Flash, F. Wood, and V. Shalev, "The direct medical cost of cardiovascular diseases, hypertension, diabetes, cancer, pregnancy and female infertility in a large HMO in Israel," Helath Policy, Vol.95, No.2-3, pp.271-276, 2010.   DOI
22 C. Stromberg, E. Aboagye, J. Hagberg, G. Bergstrom, and M. Lohela-Karlsson, "Estimating the Effect and Economic Impact of Absenteeism, Presenteeism, and Work Environment-Related Problems on Reductions in Productivity from a Managerial Perspective," Value Health, Vol.20, No.8, pp.1058-1064, 2017.   DOI
23 E. J. Benjamin, M. J. Blaha, S. E. Chiuve, M Cushman, and S. R. Das, "Heart disease and stroke statistics-2017 update: a report from the American Heart Association," Circulation, Vol.135, pp.e146-e603, 2017.   DOI
24 H. C. Kim, S. M. Cho, H. Lee, H. H. Lee, J. Baek, and J. E. Heo, "Korea hypertension fact sheet 2020: analysis of nationwide population-based data," Clinical hypertension, Vol.27, No.1, pp.1-4, 2021.   DOI
25 P. A. Heidenreich, J. G. Trogdon, O. A. Khavjou, J. Butler, K. Dracup, M. D. Ezekowitz, E. A. Finkelstein, Y. Hong, S. C. Johnston, A. Khera, D. M. Lloyd-Jones, S. A. Nelson, G. Nichol, D. Orenstein, P. W. Wilson, and Y. J. Woo, "Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association," Circulation, Vol.123, pp.933-944, 2011.   DOI
26 이근정, 최효정, 안보령, 유승미, 엄혜은, 가치기반 만성질환 통합관리를 위한 운영체계 마련 연구, 건강보험심사평가원, 2019.
27 G. E. Hardy, "The burden of chronic disease: the future is prevention. Introduction to Dr. James Marks' presentation, The Burden of Chronic Disease and the Future of Public Health," Preventing chronic disease, Vol.1, No.2, pp.1-2, 2004.
28 국민건강보험공단, 고혈압 환자 및 진료비 현황(2012-2017), 2018.
29 WHO, "Hypertension, Key facts," https://www.who.int/news-room/fact-sheets/detail/hypertension
30 고숙자, 한국의료패널로 본 만성질환으로 인한 의료이용과 의료비: 우울증을 중심으로, 보건복지포럼, 2011.
31 A. B. Schultz and D. W. Edington, "Employee health and presenteeism: a systematic review," J Occup Rehabil, Vol.17, No.3, pp.547-579, 2017.   DOI
32 D. Allen, E. W. Hines, and V. Pazdernik, "Four-year review of presenteeism data among employees of a large United States health care system: a retrospective prevalence study," Hum Resour Health, Vol.16, No.59, 2018.
33 A. B. Schultz, C. Y. Chen, and D. W. Edington, "The cost and impact of health conditions on presenteeism to employers: a review of the literature. Pharmacoeconomics," Vol.27, No.5, pp.365-378, 2009.   DOI
34 D. W Lee, J. Lee, H. R. Kim, and M. Y. Kang, "Association of long working hours and health-related productivity loss, and its differential impact by income level: A cross-sectional study of the Korean workers," J Occup Health, Vol.62, pp.1-9, 2020.
35 통계청, 2020년 12월 및 연간 소비자물가동향, 2020.